Welcome to Jianke online pharmacy! Sign in Free registration
reminder:The pictures are the real photos of the original products taken by Jianke for reference only; In case of new packaging listing, there may be update lag, please take the physical object as the standard!
Baidu certification

Pregabalin capsule (lereka)

This product is used to treat postherpetic neuralgia. More role
App download minus 10 yuan
Common name:
Pregabalin capsule
Product No.:
B14200011833
Approval No.:
H20150620 (gyzz j20160021) (inquired by the State Drug Administration)
Jianke price:
¥110.00
Product specification:
75mg*8s
Manufacturer:
Pfizer manufacturing Deutschland GmbH (betriebstate Freiburg) (Germany) (sub packaged by Pfizer Pharmaceutical Co., Ltd.)
number        Quantity:
Add to list
Tips:
This product is a prescription drug. Please buy it with the prescription paper; Delivered by Jianke offline drugstore
 
(for assistance, please call400-086-5111
Jianke promises:
Genuine guarantee
Bank remittance / transfer online payment
  • Product introduction
  • instructions
  • Qualification certificate
  • Relevant information
Product name Pregabalin capsule (lereka)
Main raw materials Each capsule contains 75 mg pregabalin.
Main role This product is used to treat postherpetic neuralgia.
Product specification 75mg*8s
Usage and dosage This product can be taken with food or alone. The recommended dose of this product is 75 or 150mg each time, twice a day; Or 50mg or 100mg each time, 3 times a day. The initial dose can be 75mg each time, twice a day; Or 50mg each time, 3 times a day. It can be increased to 150mg twice a day within 1 week according to the curative effect and tolerance. As this product is mainly excreted and cleared by the kidney, the dose should be adjusted for patients with renal dysfunction. The above recommended dose is applicable to creatinine clearance ≥ 60 ml / min. If the pain of patients who have not been fully relieved after taking this product 300mg / day for 2-4 weeks can tolerate this product, it can be increased to 300mg each time, twice a day, or 200mg each time, three times a day (600mg / day). Because the adverse reactions are dose-dependent and can lead to higher withdrawal rate, the dose of more than 300mg / day should only be used for patients with persistent pain who tolerate the dose of 300mg / day. If it is necessary to stop pregabalin, it is recommended to gradually reduce it for at least one week.
manufacturing enterprise Pfizer manufacturing Deutschland GmbH (betriebstate Freiburg) (Germany) (sub packaged by Pfizer Pharmaceutical Co., Ltd.)
Jianke commitment
  • Genuine guarantee, formal invoice

    Jianke.com is an approved (B2C) Internet drug legitimate business enterprise in Guangdong Province. It signs a direct supply agreement with the manufacturer and can issue formal invoices for the purchased goods.

  • Private packaging, privacy protection

    When jianke.com packages and delivers goods, the appearance of the packing box only displays the necessary information for delivery, and the name of the purchased goods will not appear. The specific shopping list is in the package to protect the privacy of customers.

  • Efficient logistics and safe arrival

    All products of jianke.com adopt the door-to-door distribution mode of third-party logistics. They are delivered to the nearest warehouse according to your distribution address, so as to deliver them to you on time.

  • Three warehouses to ensure inventory

    Jianke.com has three warehouses in Guangzhou, Dongguan and Wuhan, equipped with first-class equipment, constant temperature and humidity to ensure drug quality. Specially assigned person to manage and ensure product inventory.

[drug name] Pregabalin capsule (lereka)

[common name] Pregabalin capsule

[specification and model] 75mg*8s

[manufacturer] Pfizer manufacturing Deutschland GmbH (betriebstate Freiburg) (Germany) (sub packaged by Pfizer Pharmaceutical Co., Ltd.)

[drug type] Western medicine

[approval No.] H20150620 (gyzz j20160021)

[validity period] 36 months

[functional indications] This product is used to treat postherpetic neuralgia.

[usage and dosage] This product can be taken with food or alone. The recommended dose of this product is 75 or 150mg each time, twice a day; Or 50mg or 100mg each time, 3 times a day. The initial dose can be 75mg each time, twice a day; Or 50mg each time, 3 times a day. It can be increased to 150mg twice a day within 1 week according to the curative effect and tolerance. As this product is mainly excreted and cleared by the kidney, the dose should be adjusted for patients with renal dysfunction. The above recommended dose is applicable to creatinine clearance ≥ 60 ml / min. If the pain of patients who have not been fully relieved after taking this product 300mg / day for 2-4 weeks can tolerate this product, it can be increased to 300mg each time, twice a day, or 200mg each time, three times a day (600mg / day). Because the adverse reactions are dose-dependent and can lead to higher withdrawal rate, the dose of more than 300mg / day should only be used for patients with persistent pain who tolerate the dose of 300mg / day. If it is necessary to stop pregabalin, it is recommended to gradually reduce it for at least one week.

[adverse reactions] It mainly includes dizziness, drowsiness, ataxia, blurred consciousness, fatigue, abnormal thinking, blurred vision, dyskinesia, dry mouth, edema, weight gain and & quot; Abnormal thinking & quot; (mainly difficulty in concentration / attention). Refer to the product manual.

[precautions] This product may cause peripheral edema. Patients with congestive heart failure with cardiac function grade III or IV should use it with caution. Dizziness and drowsiness associated with this product may affect the ability to drive or operate machinery. Creatine kinase may increase after taking. If it is suspected or diagnosed as myopathy or creatine kinase increases significantly, this product should be stopped. This product may cause physical dependence. Pregnant women should use it with caution. Lactating women should stop lactation during medication. It should not be used for patients ≤ 17 years old. Please read the instructions carefully and follow the doctor's advice.

[taboo] It is forbidden to be allergic to the active ingredients or any excipients contained in this product.

[listing Permit Holder] Pfizer manufacturing Deutschland GmbH (betriebstate Freiburg) (Germany) (sub packaged by Pfizer Pharmaceutical Co., Ltd.)

[packaging unit] box

[main ingredients] Each capsule contains 75 mg pregabalin.

[character] This product is a hard capsule with white to off white powder.

[medication for pregnant and lactating women] Data on pregnancies using pregabalin are insufficient. Animal studies have shown that lereka has reproductive toxicity. The possible risk of lerika to humans is unknown. Lereka should not be taken during pregnancy unless necessary (the benefits of taking drugs for pregnant women significantly outweigh the potential risks of drugs to the fetus). Women of childbearing age must use effective contraceptives. It is unclear whether pregabalin is secreted by breast milk; However, lerika can be secreted through rat milk. Therefore, breastfeeding during pregabalin treatment is not recommended.

[medication for children] Due to insufficient data on safety and efficacy in this population, lereka is not recommended for children and adolescents younger than 12 years old (12-17 years old).

[medication for elderly patients] Elderly patients (over 65 years of age) may need to be reduced due to decreased renal function (see

[storage] Seal and store in a dry place

Praise degree

zero%

    reminder

    Dear customer:

    In case of emergency, please call the ordering hotline400-086-5111Consult a health care professional pharmacist.

    Pregabalin capsule (lereka)

    ¥110.00

    reminder

    To ensure your privacy, please enter the verification code and click "confirm callback". Our customer service staff will call back the phone number you entered later!

    Please enter the correct verification code!
    Loding...
    Can't see clearly. Change one

    Dear customer:

    Your callback failed this time. Please re-enter the verification code to try. Thank you!